6;9 Translocation in myelodysplastic syndrome

Cancer Genetics and Cytogenetics

Volumn 112, Issue 1, 1999, Pages 57-59

  Shapira, Michael Y ^a   Hirshberg, Boaz ^a   Amir, Gail ^a   Rund, Deborah ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GRANULOCYTE COLONY STIMULATING FACTOR; VANCOMYCIN;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 6; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; FATALITY; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PRELEUKEMIA; PRIORITY JOURNAL; REFRACTORY ANEMIA; SEPTIC SHOCK;

ADOLESCENT; ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; HUMANS; KARYOTYPING; MALE; MYELODYSPLASTIC SYNDROMES; TRANSLOCATION, GENETIC;

EID: 0033167061     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00256-8     Document Type: Article

References (17)

1. Musilova J., Michalova K., Zemanova Z., Neuwirthova R., Dohnalova A. Karyotype at diagnosis, subsequent leukemic transformation and survival in myelodysplastic syndrome. Czechoslovak MDS Cooperative Group. Leuk Res. 19:1995;303-308.
2. Rowley J.D., Potter D. Chromosomal banding patterns in acute nonlymphocytic leukemia. Blood. 47:1976;705-721.
3. Soekarman D., Von Lindren M., Daenen S., de Jong B., Fonatsch C., Heinze B., Bartram C., Hagemeijer A., Grosveld G. The translocation (6;9)(p23;q34) shows consistent rearrangement to two genes and defines a myeloproliferative disorder with specific clinical feature. Blood. 79:1992;2990-2997.
4. Alsabah R., Brynes R.K., Slovak M.L., Arber D.A. Acute myeloid leukemia with t(6;9)(p23;q34), association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. Am J Clin Pathol. 107:1997;430-437.
5. Pearson M.G., Vardiman J.W., Le Beau M.M., Rowley J.D., Schwartz S., Kerman S.L., Cohen M.M., Fleischman E.W., Prigogina E.L. Increased number of marrow basophils may be associated with a t(6;9) in ANLL. Am J Hematol. 18:1985;393-403.
6. Heim S., Kristofferson U., Mandahl N., Mitelman F., Bekassy A.N., Garwicz S., Wiebe T. High resolution banding analysis of reciprocal translocation t(6;9) in acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 22:1986;195-201.
7. Ferro M.T., Resino M., Cabello P., Lopez-Yarto A., Mazariego Y.V., Garcia-Sagredo J.M., Steegman J.L. t(6;9)(p22.3;q34) in a patient with refractory anemia with excess of blasts in transformation. Cancer Genet Cytogenet. 69:1993;74-75.
8. Yunis J.J. Recurrent chromosomal defects are found in most patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 11:1984;125-137.
9. Gyger M., Infante-Rivard C., D'Angelo G., Forest L., Lussier P. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes. Am J Hematol. 28:1988;13-20.
10. Fan Y.S., Raza A., Schumer J., Jani-Sait S.N., Block A.W., Snyderman M., Sandberg A.A. Translocation t(6;9)(p22.3;q34) in myelodysplastic syndrome-refractory anemia with excess blasts. Cancer Genet Cytogenet. 29:1987;135-138.
11. Gold E.J., Conjalka M., Pelus L.M., Jhanwar S.C., Broxmeyer H., Middleton A.B., Clarkson B.D., Moore A.S. Marrow cytogenetics and cell-culture analyses of myelodysplastic syndromes. insights to pathophysiology and prognosis J Clin Oncol. 1:1983;627-634.
12. Cuneo A., Kerim S., Vandenberghe E., Van Orshoven A., Rodhain J., Bosly P., Zachee P., Louwagie A., Michaux J.L., Dal Cin P., Van Den Berghe H. Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement. Cancer Genet Cytogent. 42:1989;209-219.
13. Cunningham I., MacCallum S.J., Nicholls M.D., Byth K., Hewson J.W., Arnold B., Motum P.I., Mulligan S.P., Crane G.G. The myelodysplastic syndromes. an analysis of prognostic factors in 226 cases from a single institution Br J Haematol. 90:1995;602-606.
14. Higuchi T., Mori H., Niikura H., Omine M., Fujita K. Prognostic implications in myelodysplastic syndromes. a review of 62 cases Leuk Lymphoma. 21:1996;479-484.
15. Soekarman D., Von Lindern M., Van der Plas D.C., Selleri L., Bartram C.R., Martiat P., Culligan D., Padua R.A., Hasper-Voogt K.P., Hagemeijer A. Dek-can rearrangement in translocation (6;9)(p23;q34). Leukemia. 6:1992;489-494.
16. Fornerod M., Boer J., Van Baal S., Jaegle M., Von Lindern M., Murti K.G., Davis D., Bonten J., Buijs A., Grosveld G. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene. 10:1995;1739-1748.
17. Boer J., Mahmoud H., Raimondi S., Grosveld G., Krance R. Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation. Leukemia. 11:1997;299-300.